Managing diabetes in the middle-aged patient when loss of glycemic control occurs.
OBJECTIVE
The purpose of this article is to review the treatment of a patient with type 2 diabetes who is commonly seen in practice-specifically, a middle-aged obese patient with micro- and macrovascular complications whose A1C rises after therapeutic intervention. Discussion of glucose management, as well as hypertension, dyslipidemia, and obesity comorbidities, is included.


CONCLUSIONS
The key to successful treatment is individualization of targets and therapeutic choices. GLP-1 receptor agonists have been shown to be effective in the treatment of type 2 diabetes, including aiding with A1C reduction and weight loss. Using a combination of old and new treatments for the management of diabetes can help to improve outcomes.
USC Westside Center for Diabetes, 150 N Robertson Blvd, Suite 210, Beverly Hills, CA 90211, USA. momofmax@me.com
Anne
A
Peters
D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D004032:Diet; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D010353:Patient Education as Topic; D057285:Precision Medicine; D040242:Risk Reduction Behavior; D015431:Weight Loss
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D000960:Hypolipidemic Agents; C517652:hemoglobin A1c protein, human